Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -66,458 | -61,183 | -73,447 | 5,321 | -51,112 |
| Depreciation Amortization | 5,845 | 5,800 | 5,429 | 4,323 | 602 |
| Income taxes - deferred | -175 | -44 | -3,075 | -4,337 | -119 |
| Accounts receivable | N/A | N/A | 5,800 | -5,833 | 559 |
| Accounts payable and accrued liabilities | -2,202 | 898 | -3,378 | 1,140 | -3,528 |
| Other Working Capital | -359 | 2,601 | 6,171 | -5,524 | -7,178 |
| Other Operating Activity | 15,370 | 22,988 | 11,575 | -9,521 | 28,193 |
| Operating Cash Flow | $-47,979 | $-28,940 | $-50,925 | $-14,431 | $-32,583 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 416 | -892 | -5,413 | -5,750 | -1,146 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -11,766 |
| Investing Cash Flow | $416 | $-892 | $-5,413 | $-5,750 | $-12,912 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -159 | N/A |
| Common Stock Issued | 2 | 2,163 | 2,035 | 484 | 228,013 |
| Other Financing Activity | 0 | 0 | -163 | 0 | -5,271 |
| Financing Cash Flow | $2 | $2,163 | $1,872 | $325 | $222,742 |
| Exchange Rate Effect | 7,013 | -2,021 | 2,171 | 187 | -6,459 |
| Beginning Cash Position | 112,400 | 142,090 | 194,385 | 214,054 | 43,266 |
| End Cash Position | 71,852 | 112,400 | 142,090 | 194,385 | 214,054 |
| Net Cash Flow | $-40,548 | $-29,690 | $-52,295 | $-19,669 | $170,788 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,979 | -28,940 | -50,925 | -14,431 | -32,583 |
| Capital Expenditure | -37 | -892 | -5,413 | -6,138 | -1,146 |
| Free Cash Flow | -48,016 | -29,832 | -56,338 | -20,569 | -33,729 |